Technology

The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...

A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....